Nonculprit Lesion Complexity and Timing of Complete Revascularization in Patients Presenting With Acute Coronary Syndrome and Multivessel Disease: Insights From the BIOVASC Trial
Primary result · Composite of all-cause mortality, myocardial infarction, unplanned ischemia-driven revascularization, or cerebrovascular eventsResult — go to the resultAdjusted hazard ratio 1.49 95% CI 1.11–2.02Authors' conclusion
In patients with acute coronary syndrome and multivessel disease, patients with complex NCL experienced worse clinical outcomes at 2-year follow-up, driven by higher rates of myocardial infarction. However, no statistically significant interaction was observed between NCL complexity and the effect of immediate complete revascularization versus staged complete revascularization.
Study context
- Population
- Patients with acute coronary syndrome and multivessel diseaseenrolled in the BIOVASC trial, 550 (36.1%) had a complex nonculprit coronary lesions (NCL)
- Participants
- 1,525 patients
- Comparison
- Immediate complete revascularization and staged complete revascularization in patients with complex NCL; complex vs noncomplex NCLs
- Complex NCLn = 550
- Primary endpoint
- Composite of:
- All-cause mortality
- Myocardial infarction
- Unplanned ischemia-driven revascularization
- Cerebrovascular events
- Follow-up
- 2-year follow-up
Methodological detailsBIOVASC trial randomized patients
- BIOVASC trial randomized patients
Primary result
As reported in the abstract
Composite of all-cause mortality, myocardial infarction, unplanned ischemia-driven revascularization, or cerebrovascular…
Adjusted hazard ratio
1.49
95% CI 1.11–2.02
P = 0.01
Complex NCLvs noncomplex NCL
adjusted hazard ratio 1.49 (95% CI 1.11–2.02); P = 0.01
Further findings
Cumulative incidence
| Outcome | Immediate complete revascularization | Staged complete revascularization | Estimate | P value | |
|---|---|---|---|---|---|
| Spontaneous myocardial infarctionComplex NCLvs noncomplex NCL | adjusted hazard ratio 1.86 (95% CI 1.12–3.09) | P = 0.02 | |||
| Primary end point in patients with complex NCLImmediate complete revascularizationvs staged complete revascularization | 15.7% | 17.5% | hazard ratio 0.86 (95% CI 0.57–1.31) | P = 0.49 | |
| 0.20.5125Ratio (log scale) |
- Primary end point in patients with complex NCL: P for interaction=0.40 (complex NCL × revascularization strategy)
Original publication
Nonculprit Lesion Complexity and Timing of Complete Revascularization in Patients Presenting With Acute Coronary Syndrome and Multivessel Disease: Insights From the BIOVASC Trial. Circ Cardiovasc Interv. Published 13 November 2026. doi:10. 1161/ circinterventions. 126. 017520
Composed by AI from the published abstract and checked against it. How Briefs are made →